10.21.2025
Prevent & Delay
$1,499,984.00
36 months
EXE-T1D Phase 3: From novel pathways to therapeutic targets in type 1 diabetes
Support to study the genetic, immunological, and histological features of individuals with extremely early onset of type 1 diabetes.